Key result
Sugammadex reduced recovery time to TOF of 0.9 and extubation time compared to normal saline in children undergoing cardiac surgery.
Why the study?
Early extubation can reduce pulmonary complications after pediatric cardiac surgery, but the effects of sugammadex for postoperative respiratory management in children with congenital heart disease required evaluation.
Does sugammadex reduce extubation time and inflammatory markers in children with congenital heart disease undergoing elective cardiac surgery?
RCT (n=60)
Does sugammadex reduce extubation time and inflammatory markers in children with congenital heart disease undergoing elective cardiac surgery?
Answers are grounded in this paper and cite their sources.
Sugammadex rapidly reverses rocuronium-induced neuromuscular block, significantly reducing extubation time and postoperative inflammatory markers in children undergoing cardiac surgery for congenital heart disease.
BACKGROUND: Early extubation can reduce pulmonary complications in children undergoing cardiac surgery. The aim of this study is to evaluate the effects of sugammadex for postoperative respiratory management in children with congenital heart disease. METHODS: Sixty children with congenital heart disease undergoing elective cardiac surgery were divided into group S and group C (30 children in each group). When post tetanic twitches count (PTC) = 1-2 and train-of-four (TOF) = 0, the children in group S received sugammadex4 mg/kg for reversal of neuromuscular block at the end of surgery, and the children in group C received the same volume of normal saline. The recovery time to TOF of 0.9, the mechanical ventilation and extubation times were recorded. On the other side, the hemodynamic parameters before and 5 min after administration, and side effects were also recorded. The levels of C-reactive protein (CRP) and procalcitonin (PCT) before and 24 h after surgery were measured. RESULTS: The recovery time to TOF of 0.9 and extubation time were significantly shorter in the group S than in the group C (4.2 ± 1.4 vs 108.2 ± 26.7 min, 66.3 ± 6.5 vs 171.6 ± 23.1 min, respectively, P < 0.01). The CRP and PCT levels were found to be increased in both groups at postoperative 24 h than before surgery. Further, the levels of PCT and CRP at postoperative 24 h were lower in group S when compared to group C (median, 7 vs 17.5 mg/ml, 1.76 vs 5.22 ng/ml, respectively, P < 0.05). There were no statistical differences observed between the two groups (P> 0.05) with respect to side effects. CONCLUSION: Sugammadex is rapid and effective in reversing rocuronium-induced neuromuscular block, and significantly reduces the extubation time and the release of postoperative CRP and PCT in children with congenital heart diseases.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) conducted an RCT in Congenital heart disease (n=60). Sugammadex vs. Normal saline was evaluated on Recovery time to TOF of 0.9 (minutes) (p=< 0.01). Sugammadex reduced recovery time to TOF of 0.9 and extubation time compared to normal saline in children undergoing cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: